Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry. Anti-Cancer Agents|December 8, 2004
Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: possibility of new therapeutic strategiesSonya Trombino, Alessandra Bisio, Alessia Catassi, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 17, 2007
Nicotine, lung and cancerAlessia Grozio, Alessia Catassi, Zita Cavalieri, et al.
American Journal of Respiratory Cell and Molecular Biology|September 17, 2005
Molecular mechanisms of hexavalent chromium-induced apoptosis in human bronchoalveolar cellsPatrizia Russo, Alessia Catassi, Alfredo Cesario, et al.
Cancer|February 9, 2005
Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells: the role of nuclear factor-kappaB pathway activationPatrizia Russo, Alessia Catassi, Davide Malacarne, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2009
Inhibition of nonneuronal alpha7-nicotinic receptor for lung cancer treatmentLaura Paleari, Eva Negri, Alessia Catassi, et al.
International Journal of Cancer|December 11, 2007
Natural agents targeting the alpha7-nicotinic-receptor in NSCLC: a promising prospective in anti-cancer drug developmentAlessia Grozio, Laura Paleari, Alessia Catassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Farnesyltransferase inhibitors and human malignant pleural mesothelioma: a first-step comparative translational studyAlfredo Cesario, Alessia Catassi, Luigi Festi, et al.
International Journal of Cancer|March 28, 2009
Inhibition of non-neuronal alpha7-nicotinic receptor reduces tumorigenicity in A549 NSCLC xenograftsLaura Paleari, Fausto Sessa, Alessia Catassi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2008
Targeting alpha7-nicotinic receptor for the treatment of pleural mesotheliomaAlessia Catassi, Laura Paleari, Denis Servent, et al.
Pageof 1